eGenesis' Series A Round

eGenesis raised a round of funding on March 16, 2017.

eGenesis is a life sciences company focusing on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues and organs to the hundreds of thousands of patien…

Articles about eGenesis' Series A Round: